Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Lien, Vegard Torp; Kristiansen, Margrethe Konstanse; Pettersen, Solveig; Haugen, Mads Haugland; Krauss, Stefan; Olberg, Dag Erlend; Waaler, Jo; Klaveness, Jo.

Affiliation

Lien VT; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.
Kristiansen MK; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.
Pettersen S; Department of Tumor Biology, Institute for Cancer Research, OUS Radiumhospitalet Oslo Norway.
Haugen MH; Department of Tumor Biology, Institute for Cancer Research, OUS Radiumhospitalet Oslo Norway.
Krauss S; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo Oslo Norway.
Olberg DE; Department of Immunology and Transfusion Medicine, Oslo University Hospital Oslo Norway.
Waaler J; Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.
Klaveness J; Norsk Medisinsk Syklotronsenter AS, OUS Rikshospitalet Oslo Norway.

RSC Adv ; 10(9): 4927, 2020 Jan 29.

Article in En | MEDLINE | ID: mdl-35503286

ABSTRACT

[This corrects the article DOI 10.1039/C9RA08954C.].

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: RSC Adv Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: RSC Adv Year: 2020 Type: Article